MARKET

NGEN

NGEN

Nervgen Pharma Corp
NASDAQ
1.760
0.000
0.00%
After Hours: 1.760 0 0.00% 19:34 08/13 EDT
OPEN
1.770
PREV CLOSE
1.760
HIGH
1.820
LOW
1.733
VOLUME
553.04K
TURNOVER
--
52 WEEK HIGH
6.30
52 WEEK LOW
1.580
MARKET CAP
186.90M
P/E (TTM)
-4.3000
1D
5D
1M
3M
1Y
5Y
1D
NervGen Pharma Posts Larger Q2 2026 Loss but Strengthens Cash Position
TipRanks · 16h ago
NervGen Pharma GAAP EPS of -C$0.37
Seeking Alpha · 16h ago
*NervGen Pharma 2Q Loss/Shr C$0.32 >NGEN
Dow Jones · 16h ago
Weekly Report: what happened at NGEN last week (0803-0807)?
Weekly Report · 3d ago
Weekly Report: what happened at NGEN last week (0727-0731)?
Weekly Report · 08/03 09:05
Weekly Report: what happened at NGEN last week (0720-0724)?
Weekly Report · 07/27 09:05
Weekly Report: what happened at NGEN last week (0713-0717)?
Weekly Report · 07/20 09:05
Micron To Rally Around 87%? Here Are 10 Top Analyst Forecasts For Tuesday
Benzinga · 07/14 12:19
More
About NGEN
NervGen Pharma Corp. is a clinical-stage biotech company. The Company is engaged in developing treatments to promote nervous system repair in the settings of neurotrauma and neurologic disease. NVG-291 is in a Phase 1b/2a clinical trial in spinal cord injury and has undertaken preclinical evaluation of a new development candidate, NVG-300, in models of ischemic stroke, amyotrophic lateral sclerosis (ALS) and spinal cord injury (SCI). Its NVG-291 is a therapeutic peptide targeting nervous system repair.

Webull offers NervGen Pharma Corp stock information, including NASDAQ: NGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NGEN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NGEN stock methods without spending real money on the virtual paper trading platform.